Novel Anticancer Agents

Alex Adjei, John Buolamwini

Research output: Book/ReportBook

1 Citation (Scopus)

Abstract

This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.

Original languageEnglish (US)
PublisherElsevier Inc.
ISBN (Print)9780120885619
DOIs
StatePublished - Jan 1 2006

Fingerprint

Antineoplastic Agents
Drug Discovery
Information Science
Clinical Trials
Pharmacokinetics
Translational Medical Research
Information science
Cytostatic Agents
Imaging techniques
Clinical Studies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Novel Anticancer Agents. / Adjei, Alex; Buolamwini, John.

Elsevier Inc., 2006.

Research output: Book/ReportBook

Adjei, Alex ; Buolamwini, John. / Novel Anticancer Agents. Elsevier Inc., 2006.
@book{e8ba8b83c6c94e34b497bb98f852cdbe,
title = "Novel Anticancer Agents",
abstract = "This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.",
author = "Alex Adjei and John Buolamwini",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-088561-9.X5000-5",
language = "English (US)",
isbn = "9780120885619",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - BOOK

T1 - Novel Anticancer Agents

AU - Adjei, Alex

AU - Buolamwini, John

PY - 2006/1/1

Y1 - 2006/1/1

N2 - This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.

AB - This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.

UR - http://www.scopus.com/inward/record.url?scp=85013822535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013822535&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-088561-9.X5000-5

DO - 10.1016/B978-0-12-088561-9.X5000-5

M3 - Book

AN - SCOPUS:85013822535

SN - 9780120885619

BT - Novel Anticancer Agents

PB - Elsevier Inc.

ER -